7+ anschreiben muster ausbildung
BURLINGTON, Mass., Dec. 20, 2018 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. (Nasdaq:FLXN) will advertise basic unaudited acquirement for the fourth-quarter and full-year 2018 and accommodate acquirement advice for 2019 on Thursday, January 3, 2019, afterwards bazaar close. The aggregation will authority a appointment alarm to altercate the after-effects and the advice on Friday, January 4, 2019 at 8:30 a.m. ET.
The dial-in cardinal for the appointment alarm is 1-855-770-0022 for calm participants and 1-908-982-4677 for all-embracing participants, with Appointment ID #2660538. A alive webcast of the appointment alarm can additionally be accessed through the “Investors” tab on the Flexion Therapeutics website. A webcast epitomize will be accessible online afterwards the call.
About Flexion Therapeutics
Flexion Therapeutics (Nasdaq:FLXN) is a biopharmaceutical aggregation focused on the development and commercialization of novel, bounded therapies for the analysis of patients with musculoskeletal conditions, alpha with osteoarthritis, a blazon of degenerative arthritis. The company’s amount ethics are focus, ingenuity, tenacity, accuracy and fun. For the accomplished two years, Flexion has been called one of the Best Places to Work by the Boston Business Journal, and a Top Place to Work in Massachusetts by The Boston Globe.
Vice President, Corporate Communications and Investor Relations
Flexion Therapeutics, Inc.